Found: 70
Select item for more details and to access through your institution.
Evaluation of three MALDI‐TOF mass spectrometry libraries for the identification of filamentous fungi in three clinical microbiology laboratories in Manitoba, Canada.
- Published in:
- Mycoses, 2018, v. 61, n. 10, p. 743, doi. 10.1111/myc.12800
- By:
- Publication type:
- Article
Nontoxigenic Vibrio cholerae Septicemia in an Immunocompromised Patient.
- Published in:
- Case Reports in Infectious Diseases, 2012, p. 1, doi. 10.1155/2012/698746
- By:
- Publication type:
- Article
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012.
- Published in:
- Canadian Journal of Microbiology, 2013, v. 59, n. 12, p. 778, doi. 10.1139/cjm-2013-0614
- By:
- Publication type:
- Article
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.
- Published in:
- Canadian Journal of Microbiology, 2013, v. 59, n. 12, p. 778, doi. 10.1139/cjm-2013-0614
- By:
- Publication type:
- Article
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 533, doi. 10.1007/s40265-022-01688-1
- By:
- Publication type:
- Article
Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.
- Published in:
- Drugs, 2021, v. 81, n. 2, p. 233, doi. 10.1007/s40265-020-01443-4
- By:
- Publication type:
- Article
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
- Published in:
- Drugs, 2020, v. 80, n. 3, p. 285, doi. 10.1007/s40265-020-01257-4
- By:
- Publication type:
- Article
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
- Published in:
- Drugs, 2019, v. 79, n. 3, p. 271, doi. 10.1007/s40265-019-1055-2
- By:
- Publication type:
- Article
Correction to: Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
- Published in:
- Drugs, 2018, v. 78, n. 7, p. 787, doi. 10.1007/s40265-018-0910-x
- By:
- Publication type:
- Article
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
- Published in:
- Drugs, 2018, v. 78, n. 1, p. 65, doi. 10.1007/s40265-017-0851-9
- By:
- Publication type:
- Article
Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
- Published in:
- Drugs, 2016, v. 76, n. 18, p. 1737, doi. 10.1007/s40265-016-0667-z
- By:
- Publication type:
- Article
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.
- Published in:
- Drugs, 2016, v. 76, n. 5, p. 567, doi. 10.1007/s40265-016-0545-8
- By:
- Publication type:
- Article
Identification of a new species, Candida subhashii, as a cause of peritonitis.
- Published in:
- Medical Mycology, 2009, v. 47, n. 3, p. 305, doi. 10.1080/13693780802380545
- By:
- Publication type:
- Article
708. In Vitro Activity of Plazomicin vs. Clinical Isolates of Gram-Negative Bacilli, Including Aminoglycoside Nonsusceptible and Multidrug-Resistant Subsets, Recovered from Patients Across Canada as Part of the CANWARD study, 2011–2018.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S319, doi. 10.1093/ofid/ofz360.776
- By:
- Publication type:
- Article
128. Adequacy of Commonly Prescribed Antimicrobials for Empiric Coverage of Gram-Negative Bacterial Pathogens Recovered from the Bloodstream of Patients Attending Emergency Rooms in Canada: Analysis of Data from the CANWARD Study, 2007 to 2018.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S93, doi. 10.1093/ofid/ofz360.203
- By:
- Publication type:
- Article
Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli.
- Published in:
- Drugs, 2014, v. 74, n. 1, p. 31, doi. 10.1007/s40265-013-0168-2
- By:
- Publication type:
- Article
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination.
- Published in:
- Drugs, 2013, v. 73, n. 2, p. 159, doi. 10.1007/s40265-013-0013-7
- By:
- Publication type:
- Article
New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin.
- Published in:
- Drugs, 2010, v. 70, n. 7, p. 859, doi. 10.2165/11534440-000000000-00000
- By:
- Publication type:
- Article
Child and Adolescent Drug Abuse Prevention: A Rural Community-Based Approach.
- Published in:
- South Dakota Medicine, 2016, p. 49
- By:
- Publication type:
- Article
Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6245, doi. 10.3390/ijms25116245
- By:
- Publication type:
- Article
Compilation of 10 Years of MIRU-VNTR Data: Canadian National Tuberculosis Laboratory's Experience.
- Published in:
- Canadian Journal of Infectious Diseases & Medical Microbiology, 2022, p. 1, doi. 10.1155/2022/3505142
- By:
- Publication type:
- Article
Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 1, p. 59
- By:
- Publication type:
- Article
Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitals.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007–11.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i57
- By:
- Publication type:
- Article
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007–11 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i7
- By:
- Publication type:
- Article
Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i31
- By:
- Publication type:
- Article
Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i47
- By:
- Publication type:
- Article
Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007–11.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i23
- By:
- Publication type:
- Article
Changes in fluoroquinolone resistance over 5 years (CANWARD 2007–11) in bacterial pathogens isolated in Canadian hospitals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i39
- By:
- Publication type:
- Article
Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 7, p. 1706, doi. 10.1093/jac/dks113
- By:
- Publication type:
- Article
Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 58, n. 1, p. 202, doi. 10.1093/jac/dkl152
- By:
- Publication type:
- Article
Are fluoroquinolone-susceptible isolates of <it>Streptococcus pneumoniae</it> really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 4, p. 769, doi. 10.1093/jac/dki315
- By:
- Publication type:
- Article
Clinical Metagenomics Is Increasingly Accurate and Affordable to Detect Enteric Bacterial Pathogens in Stool.
- Published in:
- Microorganisms, 2022, v. 10, n. 2, p. N.PAG, doi. 10.3390/microorganisms10020441
- By:
- Publication type:
- Article
Antimicrobial resistance patterns of bacterial pathogens recovered from the urine of patients at Canadian hospitals from 2009 to 2020.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 6, p. 1, doi. 10.1093/jacamr/dlac122
- By:
- Publication type:
- Article
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 1, p. 1, doi. 10.1093/jacamr/dlab197
- By:
- Publication type:
- Article
Subspecies-specific sequence detection for differentiation of Mycobacterium abscessus complex.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-73607-x
- By:
- Publication type:
- Article
Frequency of MCR-1-mediated colistin resistance among Escherichia coli clinical isolates obtained from patients in Canadian hospitals (CANWARD 2008-2015).
- Published in:
- CMAJ Open, 2016, v. 4, n. 4, p. E641, doi. 10.9778/cmajo.20160080
- By:
- Publication type:
- Article
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i8, doi. 10.1093/jac/dkad065
- By:
- Publication type:
- Article
Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i2, doi. 10.1093/jac/dkad064
- By:
- Publication type:
- Article
Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i26, doi. 10.1093/jac/dkad067
- By:
- Publication type:
- Article
Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011–20.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i37, doi. 10.1093/jac/dkad068
- By:
- Publication type:
- Article
Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i17, doi. 10.1093/jac/dkad066
- By:
- Publication type:
- Article
In vitro activity of sulopenem against 1880 bacterial pathogens isolated from Canadian patients with urinary tract infections (CANWARD, 2014-21).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 12, p. 3414, doi. 10.1093/jac/dkac333
- By:
- Publication type:
- Article
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 3035, doi. 10.1093/jac/dkac275
- By:
- Publication type:
- Article
PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007-20.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
- Published in:
- 2021
- By:
- Publication type:
- journal article